SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- and long-acting insulins.

SACRAMENTO, CA – Setting a national precedent, California will sell its own state-branded insulin, making life-saving diabetes medication affordable for millions. Governor Gavin Newsom announced that ...

Emma Kleck has been totally dependent on insulin, the lifesaving medication for people living with diabetes, for 25 years. Kleck, 32, of Santa Cruz, was diagnosed with the rarer Type 1 diabetes at age ...

Improved insurance coverage, not interchangeability status, likely drove Semglee's increased adoption over Lantus. Semglee's market share rose significantly in Medicaid and employer-sponsored ...

In a move aimed at expanding affordable treatment options for millions of Americans living with diabetes, Biocon Biologics Ltd. and nonprofit generic drug manufacturer Civica, Inc. have announced a ...

The state’s CalRx Insulin Glargine will be available to consumers for a suggested retail price of $55 or less per five-pack of pens beginning Jan. 1, 2026. The insulin glargine pen agreement with ...

Civica plans to distribute its insulin glargine to pharmacies across the United States for $45 for a box of five pens. “Through the partnership we formed with Civica more than six years ago, BCBSA and ...

Rachel is a freelancer based in Echo Park, Los Angeles and has been writing and producing content for nearly two decades on subjects ranging from tech to fashion, health and lifestyle to entertainment ...

Prescriptions for the insulin glargine biosimilar Semglee increased after it was granted interchangeable status with its reference product, Lantus. Increases were seen across retail, mail order, and ...

SACRAMENTO, Calif. — California is making history in health care. Governor Gavin Newsom announced Thursday that the state will become the first in the nation to offer state-branded insulin — part of ...